Ardelyx Inc. Company Profile
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ardelyx at a glance
Ardelyx Inc. (NASDAQ: ARDX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Ardelyx is led by Mr. Michael G. Raab and employs about 489 people. The company's shares have traded publicly since 2014.
At a market capitalization of $844.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001437402, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Ardelyx do?
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Ardelyx Inc.
- Ticker
- NASDAQ: ARDX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Michael G. Raab
- Employees
- 489
- Headquarters
- 400 Fifth Avenue, Waltham, MA, United States
- Phone
- 510 745 1700
- Website
- ardelyx.com
- IPO year
- 2014
- Market cap
- $844.27M
- SEC CIK
- 0001437402
Companies similar to Ardelyx
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CYRXCryoPort Inc. | 16.90 | -2.59% | $855.97M | vs ARDX |
| CRVSCorvus Pharmaceuticals Inc. | 10.21 | -1.92% | $858.87M | vs ARDX |
| AVBPArriVent BioPharma Inc. | 16.71 | -1.07% | $823.93M | vs ARDX |
| JBIOJade Biosciences Inc. | 14.15 | +2.76% | $899.90M | vs ARDX |
| MLTXMoonLake Immunotherapeutics Class A | 10.58 | -1.76% | $900.43M | vs ARDX |
| ALMSAlumis Inc. | 6.97 | +2.95% | $902.16M | vs ARDX |
| IVAInventiva S.A. American Depository Shares | 3.32 | -1.34% | $784.25M | vs ARDX |
| GERNGeron Corporation | 1.22 | +1.67% | $783.82M | vs ARDX |